US 12139711
Antisense oligonucleotides for the treatment of Leber congenital amaurosis
granted A61PA61P27/02
Quick answer
US patent 12139711 (Antisense oligonucleotides for the treatment of Leber congenital amaurosis) held by Stichting Radboud universitair medisch centrum expires Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Stichting Radboud universitair medisch centrum
- Grant date
- Tue Nov 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61P, A61P27/02